Bulletin
Investor Alert

London Markets Open in:

Lipocine Inc.

NAS: LPCN

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 6, 2022, 6:57 p.m.

/zigman2/quotes/202742746/composite

$

0.52

Change

+0.04 +8.85%

Volume

Volume 2,042

Quotes are delayed by 20 min

/zigman2/quotes/202742746/composite

Previous close

$ 0.50

$ 0.48

Change

-0.02 -4.67%

Day low

Day high

$0.45

$0.52

Open

52 week low

52 week high

$0.36

$1.89

Open

Mahesh V. Patel

Presently, Mahesh V. Patel is Chairman, President & Chief Executive Officer of Lipocine, Inc.

He received an undergraduate degree from Karnataka University, a graduate degree from the University of Cincinnati (Ohio) and a doctorate from the University of Utah.

Transactions

Date Shares Transaction Value
05/16/2022 50,000   Acquisition at $0.77 per share. 38,500
11/18/2021 25,000   Acquisition at $1.09 per share. 27,250
12/16/2020 15,000   Disposition at $1.35 per share. 20,250
12/16/2020 45,000   Derivative/Non-derivative trans. at $0 per share. 0
12/05/2020 122,978   Derivative/Non-derivative trans. at $0 per share. 0
12/04/2020 43,500   Disposition at $1.57 per share. 68,295
12/04/2020 145,000   Derivative/Non-derivative trans. at $0 per share. 0
12/31/2019 40,000   Acquisition at $0.38 per share. 15,200
12/10/2019 25,000   Acquisition at $0.4 per share. 10,000
12/04/2019 43,500   Disposition at $0.41 per share. 17,835
12/04/2019 145,000   Derivative/Non-derivative trans. at $0 per share. 0
11/26/2019 21,928   Acquisition at $0.43 per share. 9,429
11/26/2019 1,100   Acquisition at $0.43 per share. 473
11/26/2019 700   Acquisition at $0.43 per share. 301
11/26/2019 1,272   Acquisition at $0.43 per share. 546
11/18/2019 4,810   Acquisition at $0.42 per share. 2,020
11/18/2019 40,259   Acquisition at $0.4 per share. 16,103
11/18/2019 4,931   Acquisition at $0.4 per share. 1,972
05/24/2019 2,500   Award at $1.64 per share. 4,100
05/24/2019 473   Award at $1.6 per share. 756
05/24/2019 2,500   Award at $1.59 per share. 3,975
05/24/2019 4,527   Award at $1.58 per share. 7,152
12/29/2017 6,000   Disposition at $3.48 per share. 20,880
12/29/2017 15,000   Derivative/Non-derivative trans. at $0 per share. 0

Officers and Executives

Dr. Mahesh V. Patel
Chairman, President, Chief Executive Officer & CFO
Dr. Anthony DelConte
Chief Medical Director
Dr. Nachiappan Chidambaram
Vice President-Product Development
Mr. John W. Higuchi
Director
Ms. Krista Fogarty
Chief Accounting Officer
Mr. Hans Vitzthum
Head-Investors Relation Contact
Dr. Jill M. Jene
Independent Director
Dr. Spyros Papapetropoulos
Independent Director
Dr. Richard Dana Ono
Independent Director
Mr. Jeffrey Arvin Fink
Independent Director
Link to MarketWatch's Slice.